President Trumps FY 2027 Budget Request Proposes Significant Reductions to Domestic HIV Funding and Structural Overhaul of Public Health Agencies

On April 3, 2026, the White House released the President’s Fiscal Year (FY) 2027 budget request, marking the second major fiscal roadmap of the administration’s second term. The document outlines a sweeping reorganization of federal health agencies and proposes a $1.6 billion reduction in domestic HIV/AIDS funding, representing a 35% decline from the final FY 2026 enacted levels. This budgetary blueprint prioritizes the consolidation of health programs under a new executive agency while calling for the total elimination of several long-standing prevention and housing initiatives.

While a presidential budget request serves as a statement of administrative priorities and policy direction, the ultimate authority to allocate federal dollars—the "power of the purse"—resides with the United States Congress. Historically, lawmakers have often diverged from executive requests; for instance, despite the administration’s call for reduced HIV funding in FY 2026, Congress ultimately appropriated funds that aligned closely with prior-year levels. However, the FY 2027 request signals a persistent effort by the executive branch to shift the federal government’s approach to infectious disease management and public health infrastructure.

A Strategic Shift: The Administration for Healthy America

Central to the FY 2027 proposal is the creation of the Administration for Healthy America (AHA), a new agency designed to house programs currently managed by the Health Resources and Services Administration (HRSA) and the Centers for Disease Control and Prevention (CDC). Although Congress rejected the creation of the AHA during the FY 2026 appropriations process, the administration has doubled down on the proposal for the upcoming fiscal year.

Under this plan, the Ryan White HIV/AIDS Program and the Health Center Program would be transferred from HRSA to the AHA. The administration argues that this move will allow for better alignment of priorities and more efficient management of HIV/AIDS initiatives. Furthermore, the Office of Infectious Disease and HIV/AIDS Policy (OIDP), which currently operates under the Office of the Assistant Secretary for Health, would also be absorbed into the AHA. The budget allocates $7.6 million to the OIDP within this new framework to coordinate national strategies and address antibiotic-resistant organisms and nosocomial infections alongside HIV and viral hepatitis.

Massive Reductions in HIV Prevention and Research

The most significant fiscal contractions in the FY 2027 request are directed at the CDC’s domestic HIV prevention efforts. The budget proposes the total elimination of core HIV prevention funding at the CDC, which historically accounts for approximately 91% of all federal domestic prevention spending. While the administration proposes to maintain $220 million for the Ending the HIV Epidemic (EHE) initiative—an effort originally launched during the first Trump administration—this funding would be moved to the AHA, leaving the CDC’s traditional HIV prevention division without a dedicated budget.

This proposed $794 million decrease represents a 78% drop from the $1 billion allocated in FY 2026. Additionally, the budget seeks to consolidate separate funding lines for viral hepatitis, sexually transmitted infections (STIs), and tuberculosis prevention into a single $300 million block. This consolidated figure is $70 million less than the combined total of these individual accounts in the previous fiscal year.

The research sector also faces substantial hurdles under the new request. The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is slated for an $1.8 billion cut, reducing its budget from $6.5 billion to $4.8 billion. As the world’s largest funder of HIV research, NIAID’s 27% reduction could significantly slow the development of new treatments, vaccines, and cure strategies. While specific allocations for domestic HIV research within the NIH were not fully detailed, the overall downward trend in NIAID funding suggests a contraction in the federal commitment to biomedical HIV research.

The Elimination of Social Safety Nets: HOPWA and Ryan White Part F

The FY 2027 budget request proposes the complete elimination of the Housing Opportunities for Persons with AIDS (HOPWA) program. Administered by the Department of Housing and Urban Development (HUD), HOPWA is the only federal program dedicated solely to the housing needs of low-income individuals living with HIV. In FY 2026, the program received $529 million to provide housing assistance and supportive services to prevent homelessness among vulnerable populations. Proponents of the program argue that housing stability is a clinical necessity, as individuals with stable housing are significantly more likely to achieve viral suppression and remain in care.

Within the Ryan White HIV/AIDS Program, the administration has proposed a $2.5 billion funding level, which is a $74 million (3%) decrease from FY 2026. This reduction is primarily driven by the proposed elimination of Part F of the program. Ryan White Part F supports several critical specialized initiatives, including:

• The Special Projects of National Significance (SPNS), which fund the development of innovative models of care.
• The AIDS Education and Training Centers (AETCs), which provide essential training for healthcare providers.
• The Dental Reimbursement Program and Community-Based Dental Partnership Program.
• Components of the Minority AIDS Initiative (MAI).

Impact on Racial and Ethnic Minorities

The status of the Minority AIDS Initiative (MAI) remains precarious under the FY 2027 request. Established in 1998 to address the disproportionate impact of the epidemic on racial and ethnic minority communities, the MAI receives funding through various agencies. The FY 2027 proposal eliminates $119 million in MAI funding previously directed to the Substance Abuse and Mental Health Services Administration (SAMHSA). Furthermore, $56 million in MAI funding within the Secretary’s Minority HIV/AIDS Fund is also slated for elimination. Combined with the cuts to Ryan White Part F, these measures represent a significant withdrawal of targeted resources for communities of color, who continue to bear the highest burden of new HIV diagnoses in the United States.

Chronology of Administrative Actions and Executive Pressure

The release of the FY 2027 budget occurs against a backdrop of ongoing administrative actions intended to limit or redirect already appropriated funds. Throughout 2025 and early 2026, the Trump administration utilized executive orders and the rescission process to delay or cancel funding for various public health accounts.

• June 2025: The administration initiated layoffs at the CDC and sought to rescind public health grants, leading to immediate pushback from state health departments.
• Late 2025: Litigation ensued as several states, led by California Attorney General Rob Bonta, sued the administration to protect over $600 million in health funding. In some instances, courts issued Temporary Restraining Orders (TROs) requiring the federal government to reinstate grants.
• April 2026: The FY 2027 budget request is formally submitted to Congress, doubling down on the "rescission" strategy by asking lawmakers to permanently cancel previously approved spending.

These administrative maneuvers have created a climate of "funding uncertainty" for local health departments, community-based organizations, and sub-grantees. Even when Congress appropriates funds, the threat of executive delays or impoundments makes long-term programmatic planning difficult for providers on the front lines of the HIV epidemic.

Analysis of Broader Policy Implications

The proposed cuts to HIV-specific programs do not exist in a vacuum. They coincide with broader shifts in federal health policy that could further restrict access to care. For example, the 2025 federal budget reconciliation law introduced stricter work requirements for Medicaid recipients, a move that policy analysts at KFF suggest could lead to coverage losses for low-income individuals living with HIV.

Furthermore, the expiration of premium tax credits for Marketplace health plans and ongoing legal challenges to the Affordable Care Act’s (ACA) preventive services mandate—which includes access to Pre-Exposure Prophylaxis (PrEP)—add layers of complexity to the prevention landscape. Unlike the Biden administration’s previous budget requests, which included robust proposals to expand PrEP access through a national program, the FY 2027 Trump request excludes such initiatives.

While the budget maintains $5 million for the Indian Health Service (IHS) EHE activities and $157 million for EHE activities within Health Centers, the overall reduction in the public health workforce and the elimination of core prevention grants may undermine these specific investments. Without a robust national prevention infrastructure at the CDC, localized EHE efforts may struggle to scale effectively.

Conclusion and Congressional Outlook

The FY 2027 budget request serves as a clear indicator of the administration’s intent to downsize the federal role in domestic HIV prevention and housing while centralizing care programs under the proposed AHA. However, the $1.6 billion in proposed cuts faces an uphill battle in a divided Congress. Advocacy groups and public health officials have already begun mobilizing to highlight the potential risks of these reductions, noting that a 35% decline in funding could reverse decades of progress in reducing new infections and improving health outcomes.

As the appropriations process begins, the focus will shift to the House and Senate Appropriations Committees. Lawmakers will have to weigh the administration’s desire for fiscal consolidation against the clinical and social realities of an epidemic that still sees tens of thousands of new infections annually. For now, the HIV advocacy community and state health officials remain in a state of high alert, navigating both the formal budget requests and the ongoing executive actions that define the current federal health policy environment.